Study to evaluate the efficacy of FOLFIRI + aflibercept in patients with metastatic colorectal cancer previously treated with oxaliplatin with or without ACE polymorphisms
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Primary objectives: To evaluate the efficacy of FOLFIRI + aflibercept in patients with or without ACE polymorphisms in terms of progression-free survival (PFS) Primary endpoints: Progression-free survival
创建时间：
2016-09-15
